Evidence map›Paper›PMID 32717033›Full record

ArticleNeurosurgery2020

Brain-Responsive Neurostimulation for Loss of Control Eating: Early Feasibility Study.

Hemmings Wu, Sarah Adler, Dan E Azagury, Cara Bohon, Debra L Safer, Daniel A N Barbosa, Mahendra T Bhati, Nolan R Williams, Laura B Dunn, Peter A Tass and 12 more

Open access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Neurosurgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Hemmings WuDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Sarah AdlerDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Dan E AzaguryDepartment of Surgery, Stanford University School of Medicine, Stanford, California.
Cara BohonDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Debra L SaferDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Daniel A N BarbosaDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Mahendra T BhatiDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Nolan R WilliamsDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Laura B DunnDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Peter A TassDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Brian D KnutsonDepartment of Psychology, Stanford University School of Medicine, Stanford, California.
Maya YutsisDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California.
Ayesha FraserDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California.
Tricia CunninghamDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Kara RichardsonDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Tara L SkarpaasNeuroPace Inc, 455 N Bernardo Avenue, Mountain View, California.
Thomas K TchengNeuroPace Inc, 455 N Bernardo Avenue, Mountain View, California.
Martha J MorrellNeuroPace Inc, 455 N Bernardo Avenue, Mountain View, California.
Laura Weiss RobertsDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Robert C MalenkaNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
James D LockDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.
Casey H HalpernDepartment of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Stanford University · USNeuroPace (United States) · US

Funding

Transitioning Early Career Neurosurgeons to Scientific IndependenceK12NS080223 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ESKANDAR, EMAD N · 2012 to 2022
$9.2M
Responsive Neurostimulation for Loss of Control EatingUH3NS103446 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI GOLD, JOSHUA I, HALPERN, CASEY HARRISON · 2019 to 2025
$4.8M
Neurochemical and functional neuroimaging of negative and positive valence systems in binge eatingK23MH106794 · NIMH · STANFORD UNIVERSITY · PI BOHON, CARA · 2015 to 2019
$894k
NIMH NIH HHS K23 MH106794NINDS NIH HHS K12 NS080223NINDS NIH HHS UH3 NS103446
6 · The paper itself

Abstract

backgroundLoss of control (LOC) is a pervasive feature of binge eating, which contributes significantly to the growing epidemic of obesity; approximately 80 million US adults are obese. Brain-responsive neurostimulation guided by the delta band was previously found to block binge-eating behavior in mice. Following novel preclinical work and a human case study demonstrating an association between the delta band and reward anticipation, the US Food and Drug Administration approved an Investigational Device Exemption for a first-in-human study.

objectiveTo assess feasibility, safety, and nonfutility of brain-responsive neurostimulation for LOC eating in treatment-refractory obesity.

methodsThis is a single-site, early feasibility study with a randomized, single-blinded, staggered-onset design. Six subjects will undergo bilateral brain-responsive neurostimulation of the nucleus accumbens for LOC eating using the RNS® System (NeuroPace Inc). Eligible participants must have treatment-refractory obesity with body mass index ≥ 45 kg/m2. Electrophysiological signals of LOC will be characterized using real-time recording capabilities coupled with synchronized video monitoring. Effects on other eating disorder pathology, mood, neuropsychological profile, metabolic syndrome, and nutrition will also be assessed. EXPECTED OUTCOMES: Safety/feasibility of brain-responsive neurostimulation of the nucleus accumbens will be examined. The primary success criterion is a decrease of ≥1 LOC eating episode/week based on a 28-d average in ≥50% of subjects after 6 mo of responsive neurostimulation. DISCUSSION: This study is the first to use brain-responsive neurostimulation for obesity; this approach represents a paradigm shift for intractable mental health disorders.

Indexed as

BrainDeep Brain StimulationObesityFeasibility StudiesHumansNucleus AccumbensRandomized Controlled Trials as TopicBingeDBSDeep brain stimulationEating disordersLoss of controlNucleus accumbensObesityResponsive neurostimulation

Identifiers

PMID32717033
PMCPMC8599841
OpenAlexW3045709236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.